RayBiotech, Inc. Announces Comprehensive Licensing Agreement with Emory University

Sep 26, 2012, 15:41 ET from RayBiotech, Inc.

NORCROSS, Ga., Sept. 26, 2012 /PRNewswire/ -- RayBiotech, Inc. today announced that it has executed a comprehensive license agreement with Emory University.  Under the terms of the agreement, RayBiotech will have access to a broad portfolio of antibody-related reagents and technologies developed by Emory researchers.  These reagents and technologies will enable RayBiotech to rapidly expand its antibody-based products and services platforms.  The financial terms of the agreement were not disclosed.

Commenting on the license, RayBiotech's President, COO and Co-founder, Rani Huang stated, "RayBiotech has always maintained a close relationship with Emory University.  Our original antibody array technology was developed by Emory researchers, and by continuing to work with Emory we have greatly expanded upon this original technology acquisition to further strengthen our portfolio of products and services.  We look forward to a fruitful partnership with Emory for many years to come."

Clifford Michaels, PhD, Emory's Licensing Associate, Office of Technology Transfer, added, "Adding RayBiotech to the growing number of research tool and reagent companies we work with will allow for even wider distribution and dissemination of these valuable and important tools."

About RayBiotech, Inc.

In 2001 RayBiotech (http://www.raybiotech.com) introduced the first commercially available cytokine antibody array. With a focus on translating scientific knowledge into improved health, RayBiotech continues to pioneer advances in high-throughput platforms for identifying disease mechanisms, screening and validation of biomarkers and identification of drug targets.  RayBiotech products are featured in hundreds of publications, including: Nature, Nature Medicine, Cell, Lancet, PNAS and many others. Offering the largest selection of protein arrays, RayBiotech has established a reputation for high quality and innovation in the research community. A spin-off from Emory University, RayBiotech is privately owned, with headquarters in metropolitan Atlanta.

About Emory University

Emory University, recognized internationally for its outstanding liberal arts college, superb professional schools and one of the Southeast's leading health care systems, is located on a beautiful, leafy campus in Atlanta, Georgia's historic Druid Hills suburb.

Emory maintains an uncommon balance for an institution of its standing: it generates more research funding than any other Georgia university, while maintaining its traditional emphasis on teaching.

The university is enriched by the legacy and energy of Atlanta, and by collaboration among its schools, units and centers, as well as with affiliated institutions.

For More Information:

Rob Burgess, PhD
Director, Business Development
RayBiotech, Inc.
Phone: 770-729-2992
Email: rob@raybiotech.com

SOURCE RayBiotech, Inc.